{
    "2019-09-17": [
        [
            {
                "time": "2018-03-15",
                "original_text": "How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Eli Lilly",
                        "Diabetes"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-14",
                "original_text": "Why this diabetes patient fears a no-deal Brexit",
                "features": {
                    "keywords": [
                        "diabetes patient",
                        "no-deal Brexit"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-20",
                "original_text": "Factbox: Britain's insulin providers prepare for Brexit fallout",
                "features": {
                    "keywords": [
                        "insulin providers",
                        "Brexit fallout"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-10",
                "original_text": "With a backup to the backup, insulin makers say they're primed for Brexit",
                "features": {
                    "keywords": [
                        "backup",
                        "insulin makers",
                        "Brexit"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}